Pathophysiology of neurodegeneration following traumatic brain injury

West Indian Medical Journal

Volumn 61, Issue 7, 2012, Pages

  Freire, M A M ^a,b  

^a Edmond and Lily Safra International Institute of Neuroscience of Natal (ELS IINN)   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

Author keywords

Acute neural injury; Cell death; Neurodegeneration; Secondary damage

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); AMPA RECEPTOR; CYCLOOXYGENASE 2; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; KAINIC ACID RECEPTOR; METABOTROPIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEURONAL NITRIC OXIDE SYNTHASE; PADGEM PROTEIN; POTASSIUM PUMP; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; EXCITATORY AMINO ACID; GLUTAMIC ACID;

ACCIDENTAL INJURY; APOPTOSIS; ARTICLE; BRAIN NERVE CELL; CAUSE OF DEATH; CELL DEATH; CELL PROLIFERATION; EXCITOTOXICITY; EXPERIMENTAL MODEL; FALLING; HEAD INJURY; HUMAN; INFLAMMATION; NERVE DEGENERATION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHAGOCYTE; PHYSICAL DISABILITY; POSTSYNAPTIC POTENTIAL; PROTEIN DEGRADATION; RECREATION; SPINAL CORD INJURY; TRAFFIC ACCIDENT; TRAUMATIC BRAIN INJURY; BRAIN INJURY; PHYSIOLOGY; REVIEW;

BRAIN INJURIES; CELL DEATH; EXCITATORY AMINO ACIDS; GLUTAMIC ACID; HUMANS; INFLAMMATION; NERVE DEGENERATION; OXIDATIVE STRESS;

MLCS; MLOWN;

EID: 84872549218     PISSN: 00433144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. DeKosky ST, Ikonomovic MD, Gandy S. Traumatic brain injury - football, warfare, and long-term effects. N Engl J Med 2010; 363: 1293-6.
2. Jackson AB, Dijkers M, Devivo MJ, Poczatek RB. A demographic profile of new traumatic spinal cord injuries: change and stability over 30 years. Arch Phys Med Rehabil 2004; 85: 1740-8.
3. Tagliaferri F, Compagnone C, Korsic M, Servadei F, Kraus J. A systematic review of brain injury epidemiology in Europe. Acta Neurochir (Wien) 2006; 148: 255-68; discussion 68.
4. Kraus JF, Hooten EG, Brown KA, Peek-Asa C, Heye C, McArthur DL. Child pedestrian and bicyclist injuries: results of community surveillance and a case-control study. Inj Prev 1996; 2: 212-8.
5. Coronado VG, Xu L, Basavaraju SV, McGuire LC, Wald MM, Faul MD et al. Surveillance for traumatic brain injury-related deaths--United States, 1997-2007. MMWR Surveill Summ 2011; 60: 1-32.
6. Morrison B 3rd, Saatman KE, Meaney DF, McIntosh TK. In vitro central nervous system models of mechanically induced trauma: a review. J Neurotrauma 1998; 15: 911-28.
7. Finfer SR, Cohen J. Severe traumatic brain injury. Resuscitation 2001; 48: 77-90.
8. Yeleswarapu SP, Curran A. Rehabilitation after head injury. Paediatr Child Health 2010; 20: 9.
9. VNI: The Victorian Neurotrauma Initiative. The economic cost of spinal cord injury and traumatic brain injury in Australia; 2009; Available from:http://www.vni.com.au/about/cid/241/parent/0/pid/66/t/about/title/economic-cost-ofsci-and-tbi-in-australia
10. Finkelstein EA, Corso PS, Miller TR. Incidence and economic burden of injuries in the United States. New York: Oxford University Press; 2006.
11. Burns SP, Kaufman RP, Mack CD, Bulger E. Cost of spinal cord injuries caused by rollover automobile crashes. Inj Prev 2010; 16: 74-8.
12. Crandon IW, Harding-Goldson HE, McDonald A, Fearon-Boothe D, Meeks-Aitken N. The aetiology of head injury in admitted patients in Jamaica. West Indian Med J 2007; 56: 223-5.
13. Puvanachandra P, Hyder AA. Traumatic brain injury in Latin America and the Caribbean: a call for research. Salud Publica Mex 2008; 50 (Suppl 1): S3-5.
14. Morganti-Kossmann MC, Yan E, Bye N. Animal models of traumatic brain injury: is there an optimal model to reproduce human brain injury in the laboratory? Injury 2010; 41 Suppl 1: S10-3.
15. Yamaura I, Yone K, Nakahara S, Nagamine T, Baba H, Uchida K et al. Mechanism of destructive pathologic changes in the spinal cord under chronic mechanical compression. Spine 2002; 27: 21-6.
16. Park E, Velumian AA, Fehlings MG. The role of excitotoxicity in secondary mechanisms of spinal cord injury: a review with an emphasis on the implications for white matter degeneration. J Neurotrauma 2004; 21: 754-4.
17. Unterberg AW, Stover J, Kress B, Kiening KL. Edema and brain trauma. Neuroscience 2004;[129:] 1021-9.
18. Sanchez-Gomez MV, Matute C. Activation of AMPA and kainate glutamate receptors impairs the viability of oligodendrocytes in vitro. Int J Dev Biol 1996; Suppl 1: 187S-8S.
19. Guimaraes JS, Freire MAM, Lima RR, Picanço-Diniz CW, Pereira A, Gomes-Leal W. Minocycline treatment reduces white matter damage after excitotoxic striatal injury. Brain Res 2010; 1329: 182-93.
20. Choi DW. Excitotoxic cell death. J Neurobiol 1992; 23: 1261-76.
21. Guimaraes JS, Freire MAM, Lima RR, Souza-Rodrigues RD, Costa AM, dos Santos CD et al. Mechanisms of secondary degeneration in the central nervous system during acute neural disorders and white matter damage. Rev Neurol 2009; 48: 304-10.
22. Lenzlinger PM, Morganti-Kossmann MC, Laurer HL, McIntosh TK. The duality of the inflammatory response to traumatic brain injury. Mol Neurobiol 2001; 24: 169-81.
23. Arundine M, Tymianski M. Molecular mechanisms of glutamate-dependent neurodegeneration in ischemia and traumatic brain injury. Cell Mol Life Sci 2004; 61: 657-68.
24. Choi DW. Glutamate receptors and the induction of excitotoxic neuronal death. Prog Brain Res 1994; 100: 47-51.
25. Karadottir R, Cavelier P, Bergersen LH, Attwell D. NMDA receptors are expressed in oligodendrocytes and activated in ischaemia. Nature 2005; 438: 1162-6.
26. Danbolt NC. Glutamate uptake. Prog Neurobiol 2001; 65: 1-105.
27. Medina-Ceja L, Guerrero-Cazares H, Canales-Aguirre A, Morales-Villagran A, Feria-Velasco A. Structural and functional characteristics of glutamate transporters: how they are related to epilepsy and oxidative stress. Rev Neurol 2007; 45: 341-52.
28. Lipton SA, Rosenberg PA. Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med 1994; 330: 613-22.
29. Choi D. Antagonizing excitotoxicity: a therapeutic strategy for stroke? Mt Sinai J Med 1998; 65: 133-8.
30. Olney JW. Excitotoxicity: an overview. Can Dis Wkly Rep 1990; 16 (Suppl 1E): 47-57 discussion 8.
31. Arundine M, Chopra GK, Wrong A, Lei S, Aarts MM, MacDonald JF et al. Enhanced vulnerability to NMDA toxicity in sublethal traumatic neuronal injury in vitro. J Neurotrauma 2003; 20: 1377-95.
32. Lewen A, Matz P, Chan PH. Free radical pathways in CNS injury. J Neurotrauma 2000; 17: 871-90.
33. Reynolds A, Laurie C, Mosley RL, Gendelman HE. Oxidative stress and the pathogenesis of neurodegenerative disorders. Int Rev Neurobiol 2007; 82: 297-325.
34. Dawson VL, Dawson TM. Nitric oxide in neurodegeneration. Prog Brain Res 1998; 118: 215-29.
35. Garthwaite J. Concepts of neural nitric oxide-mediated transmission. Eur J Neurosci 2008; 27: 2783-802.
36. Calabrese V, Mancuso C, Calvani M, Rizzarelli E, Butterfield DA, Stella AM. Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity. Nat Rev Neurosci 2007; 8: 766-75.
37. Freire MAM, Guimaraes JS, Gomes-Leal W, Pereira A, Jr. Pain modulation by nitric oxide in the spinal cord. Front Neurosci 2009; 3: 175-81.
38. Wink DA, Miranda KM, Espey MG. Effects of oxidative and nitrosative stress in cytotoxicity. Semin Perinatol 2000; 24: 20-3.
39. Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 2007; 87: 315-424.
40. Allan SM, Rothwell NJ. Cytokines and acute neurodegeneration. Nat Rev Neurosci 2001; 2: 734-44.
41. Allan SM, Rothwell NJ. Inflammation in central nervous system injury. Philos Trans R Soc Lond B Biol Sci 2003; 358: 1669-77.
42. Freire MAM, Morya E, Faber J, Santos JR, Guimaraes JS, Lemos NAM et al. Comprehensive analysis of tissue preservation and recording quality from chronic multielectrode implants. PLoS One 2011; 6: e27554.
43. Gomes-Leal W, Corkill DJ, Freire MAM, Picanço-Diniz CW, Perry VH. Astrocytosis, microglia activation, oligodendrocyte degeneration, and pyknosis following acute spinal cord injury. Exp Neurol 2004; 190: 456-67.
44. Schnell L, Fearn S, Klassen H, Schwab ME, Perry VH. Acute inflammatory responses to mechanical lesions in the CNS: differences between brain and spinal cord. Eur J Neurosci 1999; 11: 3648-58.
45. Morganti-Kossmann MC, Rancan M, Otto VI, Stahel PF, Kossmann T. Role of cerebral inflammation after traumatic brain injury: a revisited concept. Shock 2001; 16: 165-77.
46. Morganti-Kossmann MC, Rancan M, Stahel PF, Kossmann T. Inflammatory response in acute traumatic brain injury: a double-edged sword. Curr Opin Crit Care 2002; 8: 101-5.
47. Bell MD, Perry VH. Adhesion molecule expression on murine cerebral endothelium following the injection of a proinflammagen or during acute neuronal degeneration. J Neurocytol 1995; 24: 695-710.
48. Zhang Z, Krebs CJ, Guth L. Experimental analysis of progressive necrosis after spinal cord trauma in the rat: etiological role of the inflammatory response. Exp Neurol 1997; 143: 141-52.
49. Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 1999; 22: 391-7.
50. Streit WJ. Microglia as neuroprotective, immunocompetent cells of the CNS. Glia 2002; 40: 133-9.
51. Minghetti L, Levi G. Microglia as effector cells in brain damage and repair: focus on prostanoids and nitric oxide. Prog Neurobiol 1998; 54: 99-125.
52. Love S. Oxidative stress in brain ischemia. Brain Pathol 1999; 9: 119-31.
53. Takahashi JL, Giuliani F, Power C, Imai Y, Yong VW. Interleukin-1 beta promotes oligodendrocyte death through glutamate excitotoxicity. Ann Neurol 2003; 53: 588-95.